Arthur Tzianabos

Chief Scientific Officer, Tempest Therapeutics, Inc.

Companies

Stoke Therapeutics, Inc.Chair Mar 20, 2025 to now¹
Stoke Therapeutics, Inc.Board member Jun 18, 2019 to now²
Q32 Bio Inc.Board member Mar 27, 2018 to now³
Akouos, Inc.Board member Jun 25, 2020 to Dec 2, 2022⁴
Q32 Bio Inc.Chief executive officer Mar 27, 2018 to Feb 28, 2022³
Q32 Bio Inc.President Mar 27, 2018 to Feb 28, 2022³
Tempest Therapeutics, Inc.President Dec 11, 2014 to Dec 7, 2015⁵
Tempest Therapeutics, Inc.Chief Scientific Officer Sep 12, 2013 to Dec 6, 2013⁶

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Mar 10, 2026Sold 4,355 shares at $40.00 of Stoke Therapeutics, Inc.⁷
Mar 10, 2026Exercised options 3,955 shares at $8.33 of Stoke Therapeutics, Inc.⁷
Mar 25, 2024Sold 265 shares at $24.20 of Q32 Bio Inc.⁸
Mar 25, 2024Exercised options 1,095 shares of Q32 Bio Inc.⁸
Feb 13, 2024Exercised options 31,739 shares at $2.19 of Stoke Therapeutics, Inc.¹⁰
Jan 9, 2024Sold 13,037 shares at $0.57 of Q32 Bio Inc.¹¹
Jan 1, 2024Exercised options 19,140 shares of Q32 Bio Inc.¹¹
Jan 1, 2024Exercised options 14,280 shares of Q32 Bio Inc.¹¹
Jan 9, 2023Sold 10,616 shares at $1.39 of Q32 Bio Inc.¹²
Jan 1, 2023Exercised options 19,140 shares of Q32 Bio Inc.¹³
Jan 1, 2023Exercised options 13,860 shares of Q32 Bio Inc.¹³
Nov 30, 2022U 26,930 shares of Akouos, Inc.⁹
Jan 5, 2022Sold 5,354 shares at $3.78 of Q32 Bio Inc.¹⁴
Jan 1, 2022Exercised options 13,860 shares of Q32 Bio Inc.¹⁴

The numbers on this page point here. Each one links to the record it came from.